Sotabase

Career

· Teaching Assistant, University of Toronto Mississauga2023–
· Doctor of Philosophy - PhD, Computer Science, University of Toronto2022–2027
· Research Assistant, Continuum Robotics Laboratory2021–
· Control Engineer, aUToronto2020–2022
· Research Assistant, University of Toronto Institute for Aerospace Studies2019–2019
· PacBot Mechatronics Team Lead, University of Toronto Robotics Association2019–2020
· Bachelor of Applied Science - BASc, Engineering Science, University of Toronto2017–2022

Publications (0)

CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer’s Disease
Cell Reports · 2018
79
cited
Codonopsis pilosula Polysaccharide Attenuates Tau Hyperphosphorylation and Cognitive Impairments in hTau Infected Mice
Frontiers in Molecular Neuroscience · 2018
50
cited
Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling.
International Immunopharmacology · 2021
44
cited
CK2 Phosphorylating I2PP2A/SET Mediates Tau Pathology and Cognitive Impairment
Frontiers in Molecular Neuroscience · 2018
39
cited
Inhibition of proliferation-linked signaling cascades with atractylenolide I reduces myofibroblastic phenotype and renal fibrosis.
Biochemical Pharmacology · 2020
35
cited
Zinc induces CDK5 activation and neuronal death through CDK5-Tyr15 phosphorylation in ischemic stroke
Cell Death and Disease · 2018
34
cited
MicroRNA-455 regulates migration and invasion of human hepatocellular carcinoma by targeting Runx2.
Oncology Report · 2016
32
cited
Application of artificial neural networks in detection and diagnosis of gastrointestinal and liver tumors
World Journal of Clinical Cases · 2020
28
cited
Resveratrol ameliorates lipopolysaccharide-induced anxiety-like behavior by attenuating YAP-mediated neuro-inflammation and promoting hippocampal autophagy in mice.
Toxicology and Applied Pharmacology · 2020
25
cited
Chk1 Inhibition Ameliorates Alzheimer’s Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling
Neurotherapeutics · 2022
24
cited
CIP2A-promoted astrogliosis induces AD-like synaptic degeneration and cognitive deficits
Neurobiology of Aging · 2019
21
cited
Fibroblast growth factor 10 ameliorates neurodegeneration in mouse and cellular models of Alzheimer's disease via reducing tau hyperphosphorylation and neuronal apoptosis
Aging Cell · 2023
15
cited
Genistein Decreases APP/tau Phosphorylation and Ameliorates Aβ Over- production Through Inhibiting CIP2A.
Current Alzheimer Research · 2019
14
cited
Polyphyllin I attenuates cognitive impairments and reduces AD‐like pathology through CIP2A‐PP2A signaling pathway in 3XTg‐AD mice
The FASEB Journal · 2020
14
cited
Acetylation of AMPA Receptors Regulates Receptor Trafficking and Rescues Memory Deficits in Alzheimer's Disease
iScience · 2020
13
cited
ChK1 activation induces reactive astrogliosis through CIP2A/PP2A/STAT3 pathway in Alzheimer's disease
The FASEB Journal · 2022
12
cited
Upregulation of KDM6B contributes to lipopolysaccharide-induced anxiety-like behavior via modulation of VGLL4 in mice
Behavioural Brain Research · 2021
12
cited
Increased CDK4 protein expression predicts a poor prognosis in mucosal melanoma associated with the p16INK4a-CDK4-pRb pathway.
International Journal of Clinical and Experimental Pathology · 2019
11
cited
Hydrogen sulfide ameliorates lipopolysaccharide-induced anxiety-like behavior by inhibiting checkpoint kinase 1 activation in the hippocampus of mice
Experimental Neurology · 2023
9
cited
New Insights into Alzheimer’s Disease: Novel Pathogenesis, Drug Target and Delivery
Pharmaceutics · 2023
9
cited
Sotabase